Karyopharm to participate at the jefferies global healthcare conference

Newton, mass. , may 29, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the jefferies global healthcare conference in a fireside chat on wednesday, june 5, 2024 at 1:00 p.m.

KPTI Ratings Summary

KPTI Quant Ranking